Eric F. Morand

机构：Novartis (Switzerland), Monash Medical Centre, St Vincent's Hospital Melbourne, Monash Health, Centre for Inflammation Research, Monash University · ORCID：0000-0002-9507-3338

发表论文 601 篇 · 总被引 22806 次 · h-index 75

代表论文

• Progress in the use of type I interferon blockade in systemic lupus erythematosus (2025 · Expert Opinion on Biological Therapy · 被引 7)
• Key considerations for advancing chimeric antigen receptor (CAR) T-cell therapy for systemic lupus erythematosus (SLE): a multi-partner/disciplinary working group perspective (2025 · RMD Open · 被引 5)
• Prevalence and outcomes of a pilot definition of severe refractory systemic lupus erythematosus: observations from a multinational Asia-Pacific cohort (2025 · Arthritis Research & Therapy · 被引 5)
• Design of Two Randomized, Placebo-Controlled, Phase 3 Trials of Deucravacitinib, an Oral, Selective, Allosteric TYK2 Inhibitor, in Systemic Lupus Erythematosus (2025 · Advances in Therapy · 被引 4)
• Regulatory T cell therapy for Sjögren's disease: From pathogenesis to targeted treatment (2025 · Journal of Translational Autoimmunity · 被引 4)
• 10 years in lupus – progress, but not enough (2025 · Trends in Molecular Medicine · 被引 3)